ProShares UltraShort NASDAQ Biotechnology
16 hedge funds and large institutions have $15.6M invested in ProShares UltraShort NASDAQ Biotechnology in 2014 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 2 closing their positions.
Holders
16
Holders Change
+7
Holders Change %
+77.78%
% of All Funds
0.46%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
9
Increased
4
Reduced
1
Closed
2
Calls
$2.23M
Puts
$488K
Net Calls
+$1.74M
Net Calls Change
-$2.21M
Top Buyers
| 1 |
FAM
1
Fred Alger Management
New York
|
$1.71M |
| 2 |
FTUS
2
Flow Traders U.S.
New York
|
$1.07M |
| 3 |
3
Jane Street
New York
|
$774K |
| 4 |
BMO
4
Beck Mack & Oliver
New York
|
$602K |
| 5 |
5
HighTower Advisors
Chicago,
Illinois
|
$565K |
Top Sellers
| 1 |
1
Zurich Cantonal Bank
Zurich,
Switzerland
|
$0 |
| 2 |
ST
2
Spot Trading
Chicago,
Illinois
|
$0 |
| 3 |
U
3
UBS
Zurich,
Switzerland
|
$17K |
